Female well-being embraces physical, psychological, and emotional health, evolving through the different stages of life. Menopause, characterized by the natural decline of estrogen, often brings challenges such as vulvo-vaginal atrophy (VVA), which can significantly impact quality of life. While traditional treatments such as moisturizers and local estrogen therapies remain important, non-hormonal solutions are gaining attention. Among these, hyaluronic acid has emerged as a valuable option.
In this context, ROELMI HPC has developed ExceptionHYAL® Blossom, a nutraceutical ingredient based on advanced hyaluronans and obtained with the proprietary Full-Spectrum Technology™, designed to replicate the structure and function of natural vaginal hyaluronans.
A clinical study involving 30 menopausal women demonstrated that supplementation with ExceptionHYAL® Blossom improved vaginal health and relieved symptoms such as dryness and pain, providing effective support alongside standard therapies.